Dear customers, dear friends,

The second year under pandemic conditions draws to its end. We all had high hopes when the vaccination campaign started in early 2021. Unfortunately the virus has still more arrows in its quiver than anybody expected. Nevertheless, we can look back on a successful 30th anniversary year.

Quantitative anti-SARS-CoV-2 total antibody determination in WHO standardized units (BAU/mL)

DiaSys is particularly pleased to announce the standardization of the SARS-CoV-2 UTAB FS (UTAB = Universal Total AntiBody) assay.

> Read more

DiaSys Japan celebrates its 15th anniversary

Our subsidiary DiaSys Japan proudly celebrates its 15th anniversary this year! CEO Yoshihiko Akagi gives us a glimpse into the history of DiaSys Japan.

> Read more

DiaSys hosted virtual training for South-East Asian customers

More than 80 partners from Singapore, Thailand, Indonesia, Malaysia, Vietnam and the Philippines took part in the 3-day training.

> Read more

Ministry of Economics Rhineland-Palatinate visits DiaSys at MEDICA

We had a very successful Medica with numerous visits from new and long-standing partners at our booth.

> Read more

First training in new DiaSys Lounge in Egypt

Although it is not officially inaugurated yet, a first instrument training took place in our new DiaSys Lounge in Cairo.

> Read more

"Choosing quality" becomes a matter of the heart

Our partner from Oman, Mr. Shakeel Baig, is passionate about customer support. He regularly publishes respons® service videos on his YouTube channel.

> Read more

DiaSys presentations at SEPTIMET and EURAMET

DiaSys' immunoassay developer Thomas Masetto was invited to speak at the Stakeholder Event of the EU-funded (EMPIR) project SEPTIMET and at a EURAMET workshop.

> Read more

Successful completion of another milestone for IVDR implementation!

As every year, an audit by TÜV Rheinland took place at DiaSys in November. Everything was different this time, as the audit had an extended objective.

> Read more